Category: Stock Market

Forex Signals March 10: Oracle ORCL, BioNTech, Firefly Aerospace Earnings Preview

Posted on by Skerdian Meta

Today’s earnings announcements from Oracle Corporation, BioNTech, and Firefly Aerospace are being closely watched by investors. The findings are anticipated to shed light on the demand for enterprise clouds, the potential for biotech recovery, and the developing private space sector.
Continue reading “Forex Signals March 10: Oracle ORCL, BioNTech, Firefly Aerospace Earnings Preview” →

MU Stock Jumps on Analysts Upgrades, but High Micron Earnings Expectations Call for Caution

Posted on by Skerdian Meta

Shares of Micron Technology jumped sharply on renewed analyst optimism and strong memory pricing forecasts, though the semiconductor cycle’s inherent volatility still calls for caution. Continue reading “MU Stock Jumps on Analysts Upgrades, but High Micron Earnings Expectations Call for Caution” →

TMC Stock and USAR Rebound – NOAA Gives Green Light for Deep-Sea Mining

Posted on by Skerdian Meta

Shares of USA Rare Earth (USAR) and The Metals Company (TMC) skyrocketed when deep-sea mining regulations improved, rekindling investor interest in the strategic minerals industry.
Continue reading “TMC Stock and USAR Rebound – NOAA Gives Green Light for Deep-Sea Mining” →

Crude Oil Prices Dive to $80 As Trump Hints End of Iran War, Easing Russian Sanctions

Posted on by Skerdian Meta

Crude oil prices were initially driven higher by geopolitical worries, but they quickly reversed due to political signals and policy discussions, resulting in extreme volatility in the global energy markets. Continue reading “Crude Oil Prices Dive to $80 As Trump Hints End of Iran War, Easing Russian Sanctions” →

APLD Stock Rebounds Off Support on Power Project News—But Execution Risks Remain

Posted on by Skerdian Meta

Applied Digital shares are showing signs of recovery following a key power infrastructure update, though investor sentiment remains cautious amid execution risks and recent strategic changes. Continue reading “APLD Stock Rebounds Off Support on Power Project News—But Execution Risks Remain” →

Strategy plans Bitcoin Buy as BTC Dips Amid US-Iran Tensions

Posted on by Olumide Adesina

Michael Saylor shared a cryptic post suggesting that Strategy may be preparing for its 101st Bitcoin purchase.

Saylor shared Strategy’s Bitcoin accumulation chart, which shows the company’s purchases since August 2020, as is frequently the case with his posts. He wrote on X, “The Second Century Begins.” Strategy currently has 720,737 Bitcoin, which is worth more than $48.7 billion.

The BTC rate fell further on Friday as the stock market climbed.

The last purchase took place on February 23 and March 1, when it purchased 3,015 BTC at an average cost of $67,700 each.

Additionally, this batch represented the company’s 100th Bitcoin purchase. Bitcoin has repeatedly lost this crucial psychological support area, which has now become a resistance level, and has struggled above the $70,000 mark. The most recent factor affecting risk sentiment in cryptocurrency markets is the tensions between the US and Iran.

Bitcoin traded around $67K, which puts it below Strategy’s average purchase cost of roughly $76K.

The stock is currently trading at a discount to its underlying BTC treasury because Strategy’s basic NAV, which calculates the value of its Bitcoin holdings to its market capitalization, was slightly less than 1. Some investors were cautious since the company has continued to finance its Bitcoin accumulation strategy through debt and equity financing, as evidenced by the roughly 4.5 percent decline in strategy shares on March 6.

Oracle, OpenAI Cancel Plans to Expand Flagship Texas AI Data Center

Posted on by Olumide Adesina

Oracle and OpenAI have abandoned plans to build a flagship AI data center in Texas because of protracted negotiations over funding and OpenAI’s evolving requirements.

Cloud Costs, Weak Rebound, and Mounting Skepticism Keep Oracle Subdued
Cloud Costs, Weak Rebound, and Mounting Skepticism Keep Oracle Subdued

The breakdown of the negotiations gave Meta Platforms Inc. a chance. to intervene and consider renting developer Crusoe’s proposed expansion site in Abilene, Texas, according to people familiar with the situation. NVIDIA Corp. The top AI chipmaker assisted in facilitating Meta’s conversations with the developer, according to the people who wished to remain anonymous due to the confidential nature of the discussions.

The changing plans highlight how difficult it will be to construct AI data centers, anticipated to cost tens of billions of dollars and necessitate collaboration from numerous partners.

The widely reported Stargate project was unveiled at the White House last year alongside President Donald Trump, which includes the campus that Crusoe is building in Abilene.

Oracle and OpenAI decided against moving forward with their tentative plans to lease a sizable expansion, even though the 1,000-acre site is still under construction and some of its components are operational. At the Stargate site, Nvidia’s AI semiconductors are being used by Oracle and OpenAI.

NVIDIA got involved when Crusoe was looking for a tenant to guarantee that its products would still occupy the enlarged data center rather than those of competitor Advanced Micro Devices Inc. The people said. According to the people, Nvidia started courting Meta as a tenant for the expansion after paying Crusoe a $150 million deposit.

Oracle is committed to building 4.5 gigawatts of data center capacity for OpenAI. The companies have announced several projects in other locations, including one owned by Related Digital near Detroit, and the deal is still on track.

 

Kuwait, UAE Begin Oil Production Cuts Amid Strait of Hormuz Shutdown

Posted on by Olumide Adesina

Kuwait and the United Arab Emirates began cutting back on oil production because of the impending closure of the vital Strait of Hormuz, which impacted global supply and energy markets. Abu Dhabi National Oil stated in a statement that it is “managing offshore production levels to address storage requirements.

The price of natural gas futures is much higher today.

Petroleum Kuwait Corp. claimed that due to “Iranian threats against safe passage of ships through the Strait of Hormuz,” it was reducing production at both its refineries and oil fields. Due to Iranian threats to shipping, the Middle East war has virtually shut down Hormuz, the narrow waterway that connects the Persian Gulf to the open seas.

This has hindered exports from the world’s largest oil-producing region and contributed to London’s prices closing at nearly $93 per barrel, the highest level in over two years. As a result, consumers are looking for alternatives, which could lead to an increase in global inflation.

Kuwait’s oil cutback began with roughly 100,000 barrels per day as of early Saturday and is anticipated to nearly triple on Sunday, with further gradual reductions depending on storage levels and the status of Hormuz. As the third-largest producer in OPEC, the UAE pumped over 3.5 million barrels per day in January.

It uses export capacity that avoids the Strait of Hormuz and its international storage facilities to guarantee supply to international markets. Adnoc runs a 1.5 million barrel-per-day pipeline to Fujairah on the western coast of the United Arab Emirates. According to Adnoc, its onshore operations are carrying on as usual.

The two OPEC members’ cutbacks come after several others in the area. Earlier this week, Saudi Arabia closed its largest refinery, Qatar closed the largest liquefied natural gas plant, and Iraq began to reduce production as storage tanks began to fill up.

China Greenlights Pfizer’s Obesity Injection as Generic Rivals Approach

Posted on by Olumide Adesina

Pfizer’s new obesity treatment has been approved in China, increasing competition in a market that is about to get even more crowded because of mpending arrival of generics.

 

Pfizer announced via WeChat on Friday that the medication, ecnoglutide, is approved for long-term weight control in adults who are overweight or obese. The local startup Hangzhou Sciwind Bioscience Co. gave the company the rights to the treatment in China. in a late February deal worth $495 million.

Pfizer now joins a market dominated by multinational competitors Eli Lilly and Co. and Novo Nordisk A/S. along with Innovent Biologics, a Chinese pharmaceutical company

The approval coincides with Novo Nordisk’s Wegovy patent expiring later this month, which could lead to less expensive medications.  Novo and Lilly have already drastically reduced the cost of their medications due to the possibility of a price war from generics.

Pfizer, a relative latecomer to the obesity race, is working to increase its market share, including by acquiring Metsera for $10 billion.

Chief Executive Officer Albert Bourla stated that the company wants to participate in the “booming” obesity drug market in China and that purchasing Sciwind’s medication will provide commercial insights that will allow it to compete “in a very aggressive way.”

Similar to Wegovy, Sciwind’s medication imitates the natural hormone GLP-1, which controls hunger and blood sugar.

However, the company thinks that because of its slightly different structure, the medication is safer and more effective than other GLP-1 receptor agonists.

It was previously authorized for the treatment of diabetes. Ecnoglutide produced weight loss comparable to Eli Lilly’s Mounjaro, which targets one more hormone besides GLP-1, in a late-stage study. Patients on ecnoglutide experienced an average weight loss of 15.4 percent after 48 weeks.